Project Grant R01HD114615
- The National Institute of Child Health and Human Development (NICHD) awarded a $411,125 Project Grant (CFDA 93.865 - Child Health and Human Development Extramural Research) to Syracuse University to develop a microfluidic human placenta organoid model. The goal is to generate human trophoblast stem cells (HTSCs) from induced pluripotent stem cells and use them to create a placenta organoid system that can replicate early/mid-gestation placental development. The researchers will study the role of...
- Grant Award Summary Colorado State University received a $423,500 Project Grant from the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865), awarded July 24, 2025, with completion targeted for June 30, 2027. The project investigates the role of thyroid hormone in placental function and development during pregnancy, with emphasis on understanding how thyroid hormones regulate placental metabolism,...
- The federal Project Grant award R03HD113887, provided by the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865), supports research to investigate the role of the ZFHX4 gene in lung mesenchyme development and its potential implications for understanding the pathogenesis of lung hypoplasia in congenital diaphragmatic hernia (CDH). The $164,990 award, with a performance period from August 1, 2024 to...
- This Project Grant award from the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865) provides $485,925 to the University of Massachusetts Boston to develop novel antioxidant compounds for treating preeclampsia, a life-threatening pregnancy complication. The primary goal is to design and synthesize cationic hydrazone antioxidants that can target mitochondria to reduce oxidative stress, improve...
- The National Institute of Child Health and Human Development (NICHD) awarded a $429,000 Project Grant (CFDA 93.865: Child Health and Human Development Extramural Research) to Thomas Jefferson University, doing business as Sidney Kimmel Medical College, to develop a new imaging tool to assess placental hemodynamics during pregnancy. The study aims to determine if Subharmonic Aided Pressure Estimation (SHAPE) using contrast-enhanced ultrasound can provide a safe, non-invasive, and real-time method...
- Federal Grant Award Summary The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) awarded $429,000 in Project Grant funding to the University of Colorado-Denver for research conducted under the Child Health and Human Development Extramural Research program (CFDA 93.865). The award was obligated on August 6, 2025, with a project completion date of July 31, 2027. This R21 mechanism grant supports research utilizing induced pluripotent stem cell (iPSC)...
- Grant Award Summary The University of Pennsylvania received a $249,000 Project Grant award from the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865), effective August 1, 2025 through July 31, 2028. The award supports research to enhance understanding of common obstetric disorders through longitudinal deep-phenotyping data analysis. The project, conducted in collaboration with Dr. Yoel Sadovsky,...
- Grant Award Summary The University of Connecticut Health Center received a $249,000 Project Grant from the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865), effective September 1, 2025, through August 31, 2028. The award supports research focused on mapping intercellular trophoblast-decidual signaling and its effects on placental invasion at the maternal-fetal interface. The project delivers...
- Federal Project Grant Award Summary Duke University's Office of Research Administration is conducting a two-year research initiative funded by the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865). The project, titled "Investigating Nuclear Plasticity in the Human Placental Syncytium," is awarded $121,515 and will be performed in Durham, North Carolina, with an award date of August...
- This Project Grant award of $305,447, issued on September 2, 2024 by the National Institute of Child Health and Human Development (CFDA 93.865 - Child Health and Human Development Extramural Research), aims to identify predictive biomarkers for acute intermittent hypoxia-induced motor recovery in individuals with incomplete spinal cord injury. The research team from the University of Colorado will: 1) Validate the cellular mechanisms underlying hypoxia-induced plasticity in humans, using...
THE PHYSIOLOGICAL AND GENETIC BASIS OF GESTATIONAL ADAPTATIONS TO HYPOXIA - HYPOXIA IS A COMMON FEATURE OF GESTATIONAL COMPLICATIONS. EVEN WHEN THE ORIGINS OF HYPOXIA VARY (I.E., ENVIRONMENTAL HYPOXIA VERSUS HYPOXIA LIMITED TO THE PLACENTA), THERE ARE SHARED, INTERMEDIATE FEATURES IN PLACENTAL PHYSIOLOGY THAT ARE ALSO COMMON ACROSS MAMMALS. THESE COMMONALITIES SUGGEST THAT THERE ARE SOME FUNDAMENTAL EFFECTS OF HYPOXIA ON PLACENTAL DEVELOPMENT THAT NEGATIVELY IMPACT GESTATIONAL OUTCOMES. WE RECENTLY DEMONSTRATED THAT EVOLUTIONARY ADAPTATIONS TO CHRONIC HYPOXIA IN HIGH ELEVATION ENVIRONMENTS PROTECTS PLACENTAL AND FETAL GROWTH IN DEER MICE ACT ON MECHANISMS SHARED WITH HUMANS. THESE RESULTS POINT TO CONSERVED PROCESSES THAT ARE INVOLVED IN BOTH MEDIATING THE NEGATIVE IMPACTS OF HYPOXIA ON FETAL OUTCOMES AND PREVENTING THESE EFFECTS. IN THIS PROPOSAL, WE ADDRESS THREE KEY QUESTIONS, THE ANSWERS TO WHICH WILL SIGNIFICANTLY ADVANCE OUR UNDERSTANDING OF HOW PLACENTAL RESPONSES TO HYPOXIA CONTRIBUTE TO ADVERSE GESTATIONAL OUTCOMES (PARTICULARLY FETAL GROWTH RESTRICTION) AND THE GENETIC AND CELL TYPE-SPECIFIC MECHANISMS THAT UNDERLIE VARIATION IN SUSCEPTIBILITY TO THESE COMPLICATIONS. FIRST, WE ASK HOW INDIVIDUAL PLACENTAL CELL TYPE RESPONSES HYPOXIA CONTRIBUTE TO TISSUE-LEVEL OUTCOMES, INCLUDING IDENTIFYING THE CELL TYPES THAT ARE RESPONSIBLE FOR TISSUE-WIDE TRANSCRIPTIONAL SIGNATURES ASSOCIATED WITH FETAL GROWTH UNDER HYPOXIA. TO ANSWER THIS FIRST QUESTION, WE GENERATE CELL TYPE-SPECIFIC TRANSCRIPTOMES FROM PLACENTAL TISSUES USING SINGLE-NUCLEI RNASEQ FROM HIGHLAND-ADAPTED AND NON-ADAPTED MICE EXPERIMENTALLY ACCLIMATED DURING GESTATION TO HYPOXIA OR NORMOXIA. SECOND, WE INTERROGATE THE CIS-REGULATORY VARIATION THAT EXPLAINS CELL TYPE-SPECIFIC TRANSCRIPTIONAL VARIATION BY LINKING ALLELE-SPECIFIC GENE EXPRESSION TO CHROMATIN CONFORMATION IN PLACENTAS FROM F1 HYBRID CROSSES OF THE AFOREMENTIONED POPULATIONS, AGAIN IN AN EXPERIMENTAL FRAMEWORK. FINALLY, OUR THIRD AIM ASKS HOW THESE CELL TYPE-SPECIFIC HYPOXIA RESPONSES CONTRIBUTE TO ORGANIZATIONAL REMODELING OF THE PLACENTAL EXCHANGE STRUCTURES BY COMBINING IN VIVO HISTOLOGICAL APPROACHES AND IN VITRO EXPERIMENTAL APPROACHES FOCUSED ON CELL-AUTONOMOUS FUNCTION OF A SINGLE, IMPORTANT PLACENTAL CELL TYPE. THE PROPOSED AIMS THUS COMBINE EXPERIMENTAL APPROACHES, CUTTING-EDGE SEQUENCING ANALYSES, AND MOLECULAR AND CELLULAR BIOLOGY WITH THE BROADER GOAL OF RESOLVING THE GENETIC AND DEVELOPMENTAL PROCESSES BY WHICH NATURAL GENETIC VARIATION ALTERS PLACENTAL FUNCTION AND INFLUENCES FETAL OUTCOMES. THE RESULTS OF THIS RESEARCH WILL ADVANCE OUR UNDERSTANDING OF CONSERVED PHYSIOLOGY THAT SHAPES PLACENTAL DEVELOPMENT AND PREGNANCY IN MAMMALS, THEREBY SUPPORTING BROADER RESEARCH FOCUSED ON GESTATIONAL HEALTH AND DISEASE IN HUMANS.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $603.9k | 4/14/25 | ||
| Not listed | $425.1k | 6/24/24 | ||
| Not listed | $425.1k | 6/24/24 |